Nachrichten zur Swedish Orphan Biovitrum AB Aktie

Sobis full year 2024 revenue higher than previous estimate

Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) announces today that revenue for the full year 2024 was higher than previous…

Bulletin from Sobi’s Extraordinary General Meeting (EGM)

The Swedish Orphan Biovitrum AB (publ) (Sobi®) EGM was convened today on 11 December 2024. In accordance with the Nomination Committee’s proposals,…

Notice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ)

The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Extraordinary General Meeting…

Swedish Orphan Biovitrum AB (publ) (BIOVF) Q3 2024 Earnings Call Transcript

…

New number of shares and votes in Sobi

As per 30 September 2024, the total number of shares in Swedish Orphan Biovitrum AB (publ) (Sobi®) amounts to 356,000,049…

Swedish Orphan Biovitrum AB (publ) (BIOVF) Q2 2024 Earnings Call Transcript

…

BerGenBio Announces NCI Clinical Collaboration with UT Health San Antonio and Sobi®

Bergen, Norway, May 28, 2024, – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors…

Sobi has completed SEK 3 billion senior bond issue

Swedish Orphan Biovitrum AB (publ) (Sobi[®]) has successfully completed the inaugural issue of senior unsecured bonds of SEK 3 billion under…

Sobi establishes MTN programme with a framework amount of SEK 10 billion, publishes a base prospectus

Swedish Orphan Biovitrum AB (publ) (Sobi[®]) has established a medium term note programme with a framework amount of SEK 10…

Swedish Orphan Biovitrum AB (publ) 2024 Q1 - Results - Earnings Call Presentation

…

Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio

Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 • Total revenue increased…

dpa-AFX ProFeed